アテレクトミーデバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界のアテレクトミーデバイスの市場規模は、2023年に9億3,900万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.24%のCAGRで拡大し、2030年には15億9,600万米ドルに達すると予測されています。アテレクトミーデバイスの需要は、主に高齢者人口の増加、心血管疾患の有病率の上昇、高血圧や糖尿病などの生活習慣病の有病率の上昇、製品開拓における技術革新によって後押しされ、予測期間中のアテレクトミーデバイス市場全体の成長に貢献しています。

アテレクトミーデバイス市場は、様々な要因によって製品需要が伸びていますが、主要な要因の1つは心血管疾患の有病率の上昇です。世界保健機関（WHO）のデータ（2023年）によると、心血管疾患（CVD）は世界の主要な死因であり、毎年推定1,790万人が死亡しています。オーストラリア統計局（2023）によると、2017年から218年の間、オーストラリア人の心臓病の有病率は約20人に1人（4.8%、120万人）でした。CVDには心筋梗塞、うっ血性心不全、急性冠症候群などがあります。米国疾病予防管理センター（2023年）によると、米国では毎年約80万5,000人が心臓発作を起こしています。例えば、動脈硬化は心筋梗塞、脳卒中、末梢動脈疾患、心臓発作の背後にある主要な原因と考えられています。他の重篤なCVDSへの進行を避けるためには、動脈硬化の治療が不可欠であり、アテレクトミーデバイスの適用が一般的になっています。したがって、心血管疾患の有病率の上昇はアテレクトミーデバイスに対する需要の増加をもたらし、予測期間中のアテレクトミーデバイス市場の成長に貢献すると予測されます。

当レポートでは、世界のアテレクトミーデバイス市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 アテレクトミーデバイス市場レポートのイントロダクション

第2章 アテレクトミーデバイス市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本
• 中国

第4章 アテレクトミーデバイス市場の主な要因分析

• アテレクトミーデバイス市場の促進要因
• アテレクトミーデバイス市場の抑制要因と課題
• アテレクトミーデバイス市場の機会

第5章 アテレクトミーデバイス市場におけるポーターのファイブフォース分析

第6章 アテレクトミーデバイス市場に対するCOVID-19の影響分析

第7章 アテレクトミーデバイス市場の概要

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 アテレクトミーデバイス市場の世界企業シェア分析-主要3～5社

第9章 アテレクトミーデバイス市場の企業と製品プロファイル

• Koninklijke Philips N.V
• Medtronic
• Boston Scientific Corporation
• SCHILLER
• AngioDynamics Inc
• Cardiovascular Systems Inc
• Avinger
• BD
• Ra Medical Systems
• REX Medical

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Atherectomy Devices Market in Global (2021-2030)
• Table 4: Atherectomy Devices Market in Global by Product Type (2021-2030)
• Table 5: Atherectomy Devices Market in Global by End User (2021-2030)
• Table 6: Atherectomy Devices Market in Global by Geography (2021-2030)
• Table 7: Atherectomy Devices Market in North America (2021-2030)
• Table 8: Atherectomy Devices Market in North America by Country (2021-2030)
• Table 9: Atherectomy Devices Market in the US (2021-2030)
• Table 10: Atherectomy Devices Market in Canada (2021-2030)
• Table 11: Atherectomy Devices Market in Mexico (2021-2030)
• Table 12: Atherectomy Devices Market in Europe (2021-2030)
• Table 15: Atherectomy Devices Market in Europe by Country (2021-2030)
• Table 16: Atherectomy Devices Market in France (2021-2030)
• Table 17: Atherectomy Devices Market in Germany (2021-2030)
• Table 18: Atherectomy Devices Market in the United Kingdom (2021-2030)
• Table 19: Atherectomy Devices Market in Italy (2021-2030)
• Table 20: Atherectomy Devices Market in Spain (2021-2030)
• Table 21: Atherectomy Devices Market in Russia (2021-2030)
• Table 22: Atherectomy Devices Market in Rest of Europe (2021-2030)
• Table 23: Atherectomy Devices Market in APAC (2021-2030)
• Table 26: Atherectomy Devices Market in APAC by Country (2021-2030)
• Table 27: Atherectomy Devices Market in China (2021-2030)
• Table 28: Atherectomy Devices Market in Japan (2021-2030)
• Table 29: Atherectomy Devices Market in India (2021-2030)
• Table 30: Atherectomy Devices Market in Australia (2021-2030)
• Table 31: Atherectomy Devices Market in South Korea (2021-2030)
• Table 32: Atherectomy Devices Market in Rest of APAC (2021-2030)
• Table 33: Atherectomy Devices Market in Rest of World (2021-2030)
• Table 34: Atherectomy Devices Market in RoW by Region (2021-2030)
• Table 35: Atherectomy Devices Market in Middle East (2021-2030)
• Table 36: Atherectomy Devices Market in Africa (2021-2030)
• Table 37: Atherectomy Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Atherectomy Devices Market in Global (2021-2030)
• Figure 4: Atherectomy Devices Market in Global by Product Type (2021-2030)
• Figure 5: Atherectomy Devices Market in Global by End User (2021-2030)
• Figure 6: Atherectomy Devices Market in Global by Geography (2021-2030)
• Figure 7: Atherectomy Devices Market in North America (2021-2030)
• Figure 8: Atherectomy Devices Market in North America by Country (2021-2030)
• Figure 9: Atherectomy Devices Market in the US (2021-2030)
• Figure 10: Atherectomy Devices Market in Canada (2021-2030)
• Figure 11: Atherectomy Devices Market in Mexico (2021-2030)
• Figure 12: Atherectomy Devices Market in Europe (2021-2030)
• Figure 15: Atherectomy Devices Market in Europe by Country (2021-2030)
• Figure 16: Atherectomy Devices Market in France (2021-2030)
• Figure 17: Atherectomy Devices Market in Germany (2021-2030)
• Figure 18: Atherectomy Devices Market in the United Kingdom (2021-2030)
• Figure 19: Atherectomy Devices Market in Italy (2021-2030)
• Figure 20: Atherectomy Devices Market in Spain (2021-2030)
• Figure 21: Atherectomy Devices Market in Russia (2021-2030)
• Figure 22: Atherectomy Devices Market in Rest of Europe (2021-2030)
• Figure 23: Atherectomy Devices Market in APAC (2021-2030)
• Figure 26: Atherectomy Devices Market in APAC by Country (2021-2030)
• Figure 27: Atherectomy Devices Market in China (2021-2030)
• Figure 28: Atherectomy Devices Market in Japan (2021-2030)
• Figure 29: Atherectomy Devices Market in India (2021-2030)
• Figure 30: Atherectomy Devices Market in Australia (2021-2030)
• Figure 31: Atherectomy Devices Market in South Korea (2021-2030)
• Figure 32: Atherectomy Devices Market in Rest of APAC (2021-2030)
• Figure 33: Atherectomy Devices Market in Rest of World (2021-2030)
• Figure 34: Atherectomy Devices Market in RoW by Region (2021-2030)
• Figure 35: Atherectomy Devices Market in Middle East (2021-2030)
• Figure 36: Atherectomy Devices Market in Africa (2021-2030)
• Figure 37: Atherectomy Devices Market in South America (2021-2030)
• Figure 38: Market Drivers
• Figure 39: Market Barriers
• Figure 40: Marker Opportunities
• Figure 41: PORTER'S Five Force Analysis

Atherectomy Devices Market By Product Type (Directional, Rotational, Photoablative, And Orbital), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of cardiovascular diseases such as sudden cardiac arrest and lifestyle disorders such as hypertension

Global Atherectomy Devices Market was valued at USD 939 million in 2023, growing at a CAGR of 9.24% during the forecast period from 2024 to 2030 to reach USD 1,596 million by 2030. The demand for Atherectomy devices is primarily being boosted by increasing geriatric population, rising prevalence of cardiovascular diseases, growing prevalence of lifestyle disorders such as hypertension and diabetes, and innovation in product development thereby contributing in the overall growth of the Atherectomy devices market during the forecast period.

Atherectomy Devices Market Dynamics:

The Atherectomy devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases. Cardiovascular diseases (CVD) are the world's leading cause of death, killing an estimated 17.9 million people each year, according to data from the World Health Organization (2023). As per the Australian Bureau of Statistics (2023), during the period 2017-218, the prevalence of heart disease amongst Australians was around one in twenty (4.8% or 1.2 million people). Some of the CVDs include myocardial infarction, congestive heart failure, acute coronary syndrome, and other conditions. According to the Centers for Disease Control and Prevention (2023), approximately 805,000 people in the United States have a heart attack every year. For instance, atherosclerosis is considered a major cause behind myocardial infarctions, strokes, peripheral arterial disease, and heart attack. In order to avoid the progression to other serious CVDS, treatment of atherosclerosis becomes imperative wherein the application of Atherectomy devices have become a norm. Therefore, the increase in the prevalence of cardiovascular diseases is projected to result in the growing demand for Atherectomy devices, thereby contributing in the growth of the Atherectomy devices market during the forecast period.

Moreover, another key factor which is aiding in the growth of Atherectomy devices is the growing demand for minimally invasive devices and procedures. This can be attributed to the realization of advantages associated with minimally invasive approaches such as faster healing time and significantly less trauma compared to conventional techniques. Atherectomy devices such as directional Atherectomy is considered to be a minimally invasive treatment and has been reported to provide distinct advantage in the removal of obstructive intima hyperplastic or atherosclerotic lesions without the involvement of implantable devices such as the stents. Furthermore, Atherectomy devices help in avoiding disadvantages associated with surgical procedures such as surgical scarring and inflammation after stent implantation. Therefore, the advantages offered by arthrectomy systems are expected to further drive the growth of the Atherectomy devices during the forecast period.

Moreover, the advancements in product development such as the development of wearable Atherectomy devices is further expected to aid in the growth of the global Atherectomy devices market.

However, high capital investments in laser-related Atherectomy devices and procedure-related risks such as increased risk of distal embolization and arterial perforation may restrict the Atherectomy devices market growth.

The Atherectomy devices market experienced a period of temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. One of the major steps during the COVID surge was the suspension of numerous elective procedures and outpatient visits which reduced the demand for these devices in the market as the healthcare system guidelines across the globe temporarily focused all their efforts on the management of COVID-19 infection patient load during the initial lockdown period. Nevertheless, the Atherectomy devices market is in a recovery phase, and with the approval and administration of numerous COVID-19 vaccines around the world, activities in various fields including healthcare services have started to resume to pre-COVID levels, thereby providing ample opportunities for the Atherectomy devices to grow at significant revenue during the forecast period.

Atherectomy Devices Market Segment Analysis:

Atherectomy Devices Market by Product Type (Directional, Rotational, Photoablative, and Orbita), by End User (Hospitals, Specialty Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Atherectomy devices market, the rotational ATHERECTOMY devices category is expected to amass significant revenue share during the forecast period. This can be ascribed to their advantages such as the extremely fast spin between 140,000 and 190,000 rpm over a guidewire and allows for the creation of a channel and excises plaque by burrowing through it. Even though it is primarily indicated to be used in coronary vessels, it can also be used for plaque removal in lower extremity vessels. Another advantage of these systems is that they can combined with thrombectomy that allows for the simultaneous performance of cutting and aspiration.

Therefore, the advantages offered by the rotational Atherectomy devices is predicted to contribute in the increasing demand for this product type thereby driving the growth of the overall Atherectomy devices market during the forecast period.

North America is expected to dominate the overall Atherectomy Devices Market:

Among all the regions, North America is estimated to account for the largest share in the Atherectomy devices market. Owing to significance of key growth factors such as rising prevalence of cardiovascular diseases like coronary heart disease, peripheral arterial disease, increasing prevalence of obesity, hypertension and diabetes, and the rising aging population, along with the rising government initiatives regarding disease treatment awareness, is driving the North America Atherectomy devices market and expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, and fast regulatory approval for new products, helping the market to growth in this region.

Further, the United Sates hold the major share in North America and global Atherectomy devices market, one of the key reasons includes the rising prevalence of cardiovascular diseases in the US population. As per the data studied from 2005 to 2014 in a study quoted by the American Heart Association (2023), the estimated annual incidence of heart attack in the country was 605,000 new and 200,000 recurrent attacks. In another figures quoted by the CDC, in 2020, percent of adults who were ever been diagnosed with coronary heart disease in the country was 4.6%. Atherectomy devices are used in the drilling, grinding, and sanding of atheroma, excess cellular material, and calcium from coronary occlusion stenosis site. The high number of deaths mentioned in the above-stated fact represent the high patient burden that could have been treated had early diagnosis or treatment would have been made possible for such patients. It further represents the potential patient population present that may be present in the country at a given timeframe. Therefore, the rising incidence of coronary heart disease in the country is expected to aid in the demand for Atherectomy systems thereby resulting in more revenue generation in the United States Atherectomy devices market.

Moreover, the rising prevalence of lifestyle disorders such as the hypertension and diabetes is also considered as a key factor in the growing number of cases of atherosclerosis which in turn acts as a major risk factor for various CVDs. As per the data provided by the Centers for Disease Control and Prevention (2023), in 2018, near about 116 million people in the United States suffered from hypertension. Additionally, the data stated in the National Diabetes Report of the CDC, in 2020, 34.2 million Americans had diabetes and near about 88 million American adults exhibited prediabetic levels. Both hypertension and diabetes are considered to be one of the key risk factors for the development of atherosclerosis in patients and in turn make them susceptible to increased chances of stroke and other CVDs. Atherectomy is performed on patients with athereosclerosis to remove plaque formed in blood vessels. Therefore, the presence of large patient population suffering from hypertension and diabetes correlates to the presence of a high patient population suffering from heart diseases such as strokes and atherosclerosis which would indicate the growing need for Atherectomy devices, thereby resulting in increase in product demand supporting the growth of the United States Atherectomy devices market as well as the overall North America Atherectomy devices market during the forecast period.

Coupled with the factors mentioned above, the increasing interest of product manufacturers in the region also helps in boosting the regional product demand. For instance, in July 2020, BD acquired Straub Medical AG, a privately-held company involved in the development of medical Atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease. Such measures help in gaining the market share for the manufacturers as well as benefit end users in terms of better product pricing from the competition standpoint, thereby driving the North America ATHERECTOMY devices market forward during the forecast period.

Atherectomy Devices Market Key Players:

Some of the key market players operating in the Atherectomy devices market includes Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, AngioDynamics Inc, Cardiovascular Systems Inc, Avinger, BD, Ra Medical Systems, REX Medical and others.

Recent Developmental Activities in Atherectomy Devices Market:

In January 2022, Cardiovascular Systems Inc received the CE mark for their Diamondback 360 Coronary Orbital Atherectomy System (OAS). The device is equipped with CSI's GlideAssist that allows for easier removal, tracking, and smoother repositioning of the device.

In May 2022, Koninklijke Philips N.V introduced the new Phillips Laser System for peripheral and coronary arthrectomy procedures.

In September 2020, AngioDynamics announced the commercial launch of their Auryon Atherectomy System in the United States. The device is based on the solid-state laser technology.

Key Takeaways from the Atherectomy Devices Market Report Study

Market size analysis for current ATHERECTOMY devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Atherectomy devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Atherectomy Devices Market.

Various opportunities available for the other competitor in the Atherectomy Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Atherectomy devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ATHERECTOMY devices market growth in the coming future?

Target Audience who can be benefited from this Atherectomy Devices Market Report Study

Atherectomy Devices products providers

Research organizations and consulting companies

Atherectomy Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Atherectomy devices

Various End-users who want to know more about the Atherectomy Devices market and latest technological developments in the Atherectomy Devices market.

Frequently Asked Questions for Atherectomy Devices Market:

1. What is an Atherectomy Device?

Atherectomy devices are medical devices which help in plaque removal from peripheral as well as coronary vasculature by cutting, shaving, sanding, or vaporizing the plaque deposits.

2. What is the market for Global Atherectomy Devices?

Global Atherectomy Devices Market was valued at USD 939 million in 2023, growing at a CAGR of 9.24% during the forecast period from 2024 to 2030 to reach USD 1,596 million by 2030.

3. What are the drivers for Global Atherectomy Devices Market?

The demand for Atherectomy devices is primarily being boosted by increasing geriatric population, rising prevalence of cardiovascular diseases, growing prevalence of lifestyle disorders such as hypertension and diabetes, and innovation in product development thereby contributing in the overall growth of the Atherectomy devices market during the forecast period.

4. Who are the key players operating in Global Atherectomy Devices Market?

Some of the key market players operating in the ATHERECTOMY devices market includes Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, AngioDynamics Inc, Cardiovascular Systems Inc, Avinger, BD, Ra Medical Systems, REX Medical and others.

5. Which region has the highest share in Atherectomy Devices market?

North America is expected to dominate the overall Atherectomy Devices market during the forecast period. Factors such as rising prevalence of cardiovascular diseases such as coronary heart disease, peripheral arterial disease due to the increasing prevalence of obesity, hypertension and diabetes, the aging population, and rising government initiatives regarding disease treatment awareness, the North America ATHERECTOMY devices market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness also helped the market growth in this region.

Table of Contents

1.Atherectomy Devices Market Report Introduction

2.Atherectomy Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Atherectomy Devices Market Key Factors Analysis

• 4.1. Atherectomy Devices Market Drivers
  • 4.1.1. Rising Prevalence of Cardiovascular Diseases
  • 4.1.2. Increasing Prevalence of Lifestyle Disorders such as Diabetes and Hypertension
  • 4.1.3. Increasing Geriatric Population
  • 4.1.4. Technical Innovation in Product Development
• 4.2. Atherectomy Devices Market Restraints and Challenges
  • 4.2.1. Procedure-Related Complications
  • 4.2.2. High Capital Costs of Atherectomy Devices
• 4.3. Atherectomy Devices Market Opportunities
  • 4.3.1. Improving Insurance Coverage of Atherectomy Devices
  • 4.3.2. Addressing Procedure-Related Limitations

5. Atherectomy Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Atherectomy Devices Market

7. Atherectomy Devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Directional
  • 7.1.2. Rotational
  • 7.1.3. Photoablative
  • 7.1.4. Orbital
• 7.2. By End User
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. North America Atherectomy Devices Market, by Country
    • 7.3.1.1.1. United States
    • 7.3.1.1.2. Canada
    • 7.3.1.1.3. Mexico
  • 7.3.2. Europe
    • 7.3.2.1. Europe Atherectomy Devices Market, by Country
    • 7.3.2.1.1. France
    • 7.3.2.1.2. Germany
    • 7.3.2.1.3. United Kingdom
    • 7.3.2.1.4. Italy
    • 7.3.2.1.5. Spain
    • 7.3.2.1.6. Russia
    • 7.3.2.1.7. Rest of Europe
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. Asia-Pacific Atherectomy Devices Market, by Country
    • 7.3.3.1.1. China
    • 7.3.3.1.2. Japan
    • 7.3.3.1.3. India
    • 7.3.3.1.4. Australia
    • 7.3.3.1.5. South Korea
    • 7.3.3.1.6. Rest of Asia Pacific
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. RoW Atherectomy Devices Market, by Region
    • 7.3.4.1.1. Middle East
    • 7.3.4.1.2. Africa
    • 7.3.4.1.3. South America

8. Atherectomy Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Atherectomy Devices Market Company and Product Profiles

• 9.1. Koninklijke Philips N.V
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Medtronic
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Boston Scientific Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. SCHILLER
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. AngioDynamics Inc
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Cardiovascular Systems Inc
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Avinger
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. BD
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Ra Medical Systems
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. REX Medical
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us